About: Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on February 2010

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2010 (ast) наукова стаття, опублікована в лютому 2010 (uk) مقالة علمية نشرت في فبراير 2010 (ar) scientific article published on February 2010 (en)
publication date	wds:Q37670104-01D0B2EF-3F6C-4400-BDC7-619B18DC0EC1
publication date	2010-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37670104-5CDEA22C-FDC8-40A6-B1F5-E64B420EB6CC
language of work or name	English
exact match	wds:Q37670104-EFDC73B5-CB47-4165-A119-45CFA0A3109B
exact match	https://scigraph.springernature.com/pub.10.2165/11530560-000000000-00000
cites work	wds:Q37670104-020B8740-B8B4-4778-BF8D-CF2D6CC0B52A wds:Q37670104-E52125DF-8CCA-4C1C-B332-84E5A05C794A
cites work	MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4.
author name string	wds:Q37670104-0D6C21F8-04E0-4230-8F57-DAB99CB05721 wds:Q37670104-C7562581-1CBD-4924-98D4-D35432443E94
author name string	Diane R Mould Bruce Green
rdfs:label	Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (en) Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (nl) Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (ast)
skos:prefLabel	Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (en) Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (nl) Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (ast)
name	Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (en) Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (nl) Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (ast)
title	wds:Q37670104-6FC88599-A29F-49D2-B4BA-FD91ED5D806E
title	Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development (en)
page(s)	wds:Q37670104-1870C84D-B781-4FF4-B25C-410DAD00802C
page(s)	23-39
instance of	wds:Q37670104-3a9e74ab-d0ed-4c4d-9a27-a2e6b83361cd wds:Q37670104-BE5A57D2-571A-4AF9-872C-84609CEEF5F4
instance of	review article scholarly article
main subject	wds:Q37670104-9B9E4CBE-9FB4-4160-8453-9690B76B1F27 wds:Q37670104-BECB6F1F-2F92-46AE-BB2E-7E7934B6B5C1 wds:Q37670104-CDBBB129-D2A8-41EB-81C5-14987E6CE815
main subject	monoclonal antibody pharmacokinetics antibody
PubMed ID	wds:Q37670104-1D658D23-2CAA-4545-BE73-9DAF4B6E46EF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20055530
PubMed ID	20055530
published in	wds:Q37670104-F406619B-FC1F-4E78-B1B6-42B047E62A3E
published in	BioDrugs
issue	wds:Q37670104-03D87C9F-0E71-472B-BABF-FEAEB549F816
volume	wds:Q37670104-634ECAFF-F176-46FD-BD21-B38EF262B3C6
issue	1
volume	24
DOI	wds:Q37670104-DB916F92-3144-48FF-BE6C-36EA551078F7
DOI	http://dx.doi.org/10.2165/11530560-000000000-00000
DOI	10.2165/11530560-000000000-00000
Dimensions Publication ID	wds:Q37670104-DB907819-3175-4EED-BC20-2B91842166CC
Dimensions Publication ID	1027613921
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37670104
is cites work of	Assessments of antibody biodistribution Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose. A strategy for risk mitigation of antibodies with fast clearance. Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration. Therapeutic drug monitoring of biologics for inflammatory bowel disease Therapeutic drug monitoring in patients with inflammatory bowel disease Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies Simulations of site-specific target-mediated pharmacokinetic models for guiding the development of bispecific antibodies A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis Population pharmacokinetics and exposure-response analyses of trastuzumab in patients with advanced gastric or gastroesophageal junction cancer Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies Monitoring monoclonal antibody delivery in oncology: the example of bevacizumab Tailoring anti-TNF therapy in IBD: drug levels and disease activity Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms Pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases Compartmental tissue distribution of antibody therapeutics: experimental approaches and interpretations. Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma. Pharmacokinetic-pharmacodynamic disease progression model for effect of etanercept in Lewis rats with collagen-induced arthritis Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse A guide to rational dosing of monoclonal antibodies Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein Clinical Decision Support Tools: The Evolution of a Revolution Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial Dashboard systems: implementing pharmacometrics from bench to bedside Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosus

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software